Comparing costs of home- versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center

International Journal of Technology Assessment in Health Care

Volumn 21, Issue 4, 2005, Pages 506-510

  Elliott, Rachel A ^a   Thornton, Judith ^a   Webb, A Kevin ^b   Dodd, Mary ^b   Tully, Mary P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Antibiotic treatment; Costing methodology; Cystic fibrosis; Economic evaluation

Indexed keywords

ANTIBIOTIC TREATMENT; COSTING METHODOLOGY; CYSTIC FIBROSIS; ECONOMIC EVALUATION;

ANTIBIOTICS; COST BENEFIT ANALYSIS; DISEASES; HOSPITAL DATA PROCESSING; HOSPITALS;

PATIENT TREATMENT;

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HEALTH CARE COST; HOME CARE; HOSPITAL CARE; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RESPIRATORY TRACT INFECTION; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; COSTS AND COST ANALYSIS; CYSTIC FIBROSIS; FEMALE; GREAT BRITAIN; HOME CARE SERVICES; HOSPITALS, SPECIAL; HUMANS; INFECTION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATE MEDICINE;

EID: 27844500201     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462305050701     Document Type: Article

References (22)

1. Barber JA, Thompson S. Analysis of cost data in randomized trials: An application of the non-parametric bootstrap. Stat Med. 2000;19:3219-3236.
2. Bosso JA, Huckendubler Stephenson SE, Herbst JJ. Feasibility and cost savings of aminoglycosides in outpatients with cystic fibrosis. Drug Int Clin Pharm. 1985;19:52-54.
3. Bosworth DG, Nielson DW. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol. 1997;24:42-47.
4. Bradley J, Wallace E, Elborn J, Howard J, McCoy M. An audit of the effect of intravenous antibiotic treatment on pirometric measures of pulmonary function in cystic fibrosis. Ir J Med Sci. 1999;168:25-28.
5. Bramwell EC, Halpin DM, Duncan-Skingle F, Hodson M, Geddes DM. Home treatment of patients with cystic fibrosis using the 'Intermate': The first year's experience. J Adv Nurs. 1995;22:1063-1067.
6. Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998;3:233-245.
7. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary; 2001.
8. Donati MA, Guenette G, Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. J Pediatr. 1987;111:28-33.
9. Dyer J, Wedlock K, Law A, Langton Hewer S. Cost comparisons of domiciliary intravenous antibiotics with hospital intravenous antibiotics. Pediatr Pulmonol. 2000;(Suppl)20:A577.
10. Elphick HE, Tan A. Single versus combination intravenous antibiotic treatment for people with cystic fibrosis Cochrane Database Syst Rev. 2005;18:CD002007.
11. Elphick HE, Tan A, Ashby D, Smyth RL. Systematic reviews and lifelong diseases. BMJ. 2002;325:381-384.
12. Geddes D. Cystic fibrosis: Epidemiology and pathogenesis. In: Brewis R, Corrin B, Geddes D, Gibson G, eds. Respiratory medicine. 2nd ed. London: WB Saunders Company Ltd; 1995:1317-1329.
13. Gilbert J, Robinson T, Littlewood J. Home intravenous antibiotic treatment in cystic fibrosis. Arch Dis Child. 1988;63:512-517.
14. Kane RE, Jennison K, Wood C, Black PG, Herbst JJ. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients. Pediatr Pulmonol. 1988;4:84-89.
15. Krauth C, Jalilvand N, Wlete T, Busse R. Cystic fibrosis: Cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics. 2003;21:1001-1024.
16. Loader J, Sewell G. The current position in England concerning home-based ambulatory infusion provided under EL(95)5. Pharm J. 1998;261:R42.
17. Marco T, Asensio O, Bosque M, de Gracia J, Serra C. Home intravenous antibiotics for cystic fibrosis Cochrane Database Syst Rev. 2000:CD001917.
18. Office of Health Economics. OHE Compendium of Health Statistics. 13th ed. 2001.
19. Pond M, Newport M, Joanes D, Conway S. Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis. Eur Respir J. 1994;7:1640-1644.
20. Robson M, Abbott J, Webb K, Dodd M, Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax. 1992;47:684-689.
21. Thornton J, Elliott RA, Tully M, Webb K, Dodd M. Long-term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thorax. 2004;59:242-246.
22. Torgerson DJ, Sibbald B. What is a patient preference trial? BMJ. 1998;316:360.